Genetic polymorphism and diversity of Plasmodium vivax malaria

间日疟原虫疟疾的遗传多态性和多样性

基本信息

  • 批准号:
    7463921
  • 负责人:
  • 金额:
    $ 5.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-07-01 至 2010-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Malaria is considered as one of the most devastating global health problems due to the high morbidity and mortality it causes in the tropical parts of the world where it is endemic. Out of the 4 species that cause malaria in humans Plasmodium vivax is the most prevalent species outside tropical Africa. Although rarely fatal, P.vivax causes debilitating disease that severely affects the quality of life and economic productivity of the victims. In Sri Lanka, the main collaborating site for this study, malaria is endemic in 2/3rds of the country and is counted among the first four causes of hospital admissions in its endemic areas. Though both P.falciparum and P.vivax cause malaria in Sri Lanka, the latter species accounts for 70-80% or more of all malaria infections reported during the past decade. P.vivax genome sequence based on the the SAL-1 strain of P.vivax is almost complete and is available to the public (http:www.tigr.org/tdb/e2k1/pva1/). However, it does not provide any information on the genetic diversity or polymorphism of this parasite. Genetic variation is central to the pathogenesis of an organism and has significantly impeded progress towards the development of an effective malaria vaccine. Thus assessment of genetic diversity among parasite populations as proposed in this study has significant relevance for better understanding of its biology, for the development of strategies of disease control and to make valid estimations with regard to its origin. This study proposes an in depth analysis, including identification of single nucleotide polymorphisms (SNPs), in a 300 kb segment within the P.vivax genome by PCR-based sequencing of this region in 4 P.vivax strains with different geographical origins. Comparative genomic analysis together with the corresponding sequence in P.knowlesi, a closely related species to P.vivax is planned in addition to genotyping studies enabling the analysis of genome- wide microsatellite (MS) polymorphism and both MS and single nucleotide polymorphisms within the targeted region (300 kb) of a chromosome in patient isolates from varying geographical regions. This would enable the understanding of natural variation, population structure, genetic diversity and polymorphism, including the range of allele frequency spectrum and the patterns of linkage disequilibrium in recently archived field parasite isolates representing the global malaria endemic zones, which in turn would enable better understanding of the biology, population genetics and evolutionary history of this neglected parasite species. Malaria is one of the most important public health problems in many parts of world due to the high morbidity and mortality it causes, especially in young children. Better understanding of the genetic structure and its changes in the causative parasite, the objective of this proposed study, would enable the development of effective control strategies to combat this devastating disease that mostly affect the poor communities in the developing world.
描述(由申请人提供):由于它在世界热带地区引起的高发病和死亡率,疟疾被认为是最具破坏性的全球健康问题之一。在引起人类疟原虫疟原虫的四种物种中,是非洲热带非洲以外的最普遍的物种。尽管很少致命,但维瓦克斯会导致使人衰弱的疾病严重影响受害者的生活质量和经济生产力。在斯里兰卡,这项研究的主要合作地点,疟疾是该国2/3的地方性的,被计为在其流行地区入院的前四个原因之一。尽管在斯里兰卡引起疟原虫和维瓦克斯的疟疾,但后一种物种占过去十年中报告的所有疟疾感染中的70-80%或更多。基于P.Vivax的SAL-1菌株的P.Vivax基因组序列几乎是完整的,可以向公众使用(http:www.tigr.org/tdb/e2k1/pva1/)。但是,它没有提供有关该寄生虫的遗传多样性或多态性的任何信息。遗传变异对于生物体的发病机理至关重要,并且在开发有效的疟疾疫苗方面已经显着阻碍了进步。因此,这项研究中提出的寄生虫种群之间遗传多样性的评估对于更好地理解其生物学,制定疾病控制策略并就其起源进行有效的估计具有很大的相关性。这项研究提出了深入的分析,包括在p.vivax基因组内300 kb段中通过PCR基于PCR的测序在4 p.vivax菌株中基于PCR基因组的测序,在具有不同地理学起源的4 p.vivax菌株中对单个核苷酸多态性(SNP)进行了鉴定。比较基因组分析以及在P. knowlesi中的相应序列,除了基因分型研究外,还计划了与基因组宽的微卫星(MS)多态性分析以及MS和单核苷酸多态性分析的基因组分型研究,以及在靶向区域内(300 kb)(300 kb)(300 kb)(300 kb)的colomosome ecoprication necoption necoption necoption necoption necoption necoption ernation necoption necoption。这将使人们能够理解自然变异,人口结构,遗传多样性和多态性,包括等位基因频谱的范围以及最近存档的田间寄生虫分离株中代表全球疟疾地方性区域的链接不平衡的模式,这反过来又可以更好地了解生物学,遗传学和进化史。疟疾是世界许多地方最重要的公共卫生问题之一,因为它引起的发病率高和死亡率,尤其是在幼儿中。对这项拟议的研究的目的,更好地了解遗传结构及其在病因寄生虫中的变化将使有效的控制策略能够打击这种毁灭性疾病,主要影响发展中国家贫困社区。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dyann F Wirth其他文献

Dyann F Wirth的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dyann F Wirth', 18)}}的其他基金

Defining physiological correlates of the human malaria infectious reservoir
定义人类疟疾传染源的生理相关性
  • 批准号:
    9228305
  • 财政年份:
    2016
  • 资助金额:
    $ 5.92万
  • 项目类别:
Targeting the Mitochondrion of P. falciparum
靶向恶性疟原虫的线粒体
  • 批准号:
    9030307
  • 财政年份:
    2012
  • 资助金额:
    $ 5.92万
  • 项目类别:
Targeting the Mitochondrion of P. falciparum
靶向恶性疟原虫的线粒体
  • 批准号:
    8681306
  • 财政年份:
    2012
  • 资助金额:
    $ 5.92万
  • 项目类别:
Targeting the Mitochondrion of P. falciparum
靶向恶性疟原虫的线粒体
  • 批准号:
    9263872
  • 财政年份:
    2012
  • 资助金额:
    $ 5.92万
  • 项目类别:
Targeting the Mitochondrion of P. falciparum
靶向恶性疟原虫的线粒体
  • 批准号:
    8505368
  • 财政年份:
    2012
  • 资助金额:
    $ 5.92万
  • 项目类别:
Genome Surveillance for drug resistant malaria
耐药性疟疾的基因组监测
  • 批准号:
    7463500
  • 财政年份:
    2009
  • 资助金额:
    $ 5.92万
  • 项目类别:
Genome Surveillance for drug resistant malaria
耐药性疟疾的基因组监测
  • 批准号:
    7896435
  • 财政年份:
    2009
  • 资助金额:
    $ 5.92万
  • 项目类别:
Molecular Biomarkers for Malaria
疟疾的分子生物标志物
  • 批准号:
    7935547
  • 财政年份:
    2009
  • 资助金额:
    $ 5.92万
  • 项目类别:
Genetic polymorphism and diversity of Plasmodium vivax malaria
间日疟原虫疟疾的遗传多态性和多样性
  • 批准号:
    7621035
  • 财政年份:
    2007
  • 资助金额:
    $ 5.92万
  • 项目类别:
Genetic polymorphism and diversity of Plasmodium vivax malaria
间日疟原虫疟疾的遗传多态性和多样性
  • 批准号:
    7291160
  • 财政年份:
    2007
  • 资助金额:
    $ 5.92万
  • 项目类别:

相似海外基金

Detecting Adolescent Suicidality Biometric Signals and Dynamic Variability with Wearable Technology
利用可穿戴技术检测青少年自杀生物特征信号和动态变异性
  • 批准号:
    10731651
  • 财政年份:
    2023
  • 资助金额:
    $ 5.92万
  • 项目类别:
Substance use treatment and county incarceration: Reducing inequities in substance use treatment need, availability, use, and outcomes
药物滥用治疗和县监禁:减少药物滥用治疗需求、可用性、使用和结果方面的不平等
  • 批准号:
    10585508
  • 财政年份:
    2023
  • 资助金额:
    $ 5.92万
  • 项目类别:
CSRD Research Career Scientist Award Application
CSRD研究职业科学家奖申请
  • 批准号:
    10701136
  • 财政年份:
    2023
  • 资助金额:
    $ 5.92万
  • 项目类别:
Differences in Hospital Nursing Resources among Black-Serving Hospitals as a Driver of Patient Outcomes Disparities
黑人服务医院之间医院护理资源的差异是患者结果差异的驱动因素
  • 批准号:
    10633905
  • 财政年份:
    2023
  • 资助金额:
    $ 5.92万
  • 项目类别:
Identifying patient subgroups and processes of care that cause outcome differences following ICU vs. ward triage among patients with acute respiratory failure and sepsis
确定急性呼吸衰竭和脓毒症患者在 ICU 与病房分诊后导致结局差异的患者亚组和护理流程
  • 批准号:
    10734357
  • 财政年份:
    2023
  • 资助金额:
    $ 5.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了